NYSEARCA:BSCM Invesco BulletShares 2022 Corporate Bond ETF (BSCM) Price, Holdings, & News → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free BSCM Stock Alerts $21.16 -0.01 (-0.05%) (As of 12/15/2022) Add Compare Share Share Today's Range$21.16▼$21.1950-Day Range$21.16▼$21.1652-Week Range$21.16▼$21.47Volume278,000 shsAverage Volume568,377 shsMarket Capitalization$1.68 billionAssets Under Management$0.14Dividend Yield1.84%Net Expense Ratio0.10% Stock AnalysisStock Analysis Get Invesco BulletShares 2022 Corporate Bond ETF alerts: Email Address BSCM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BSCM ETF News HeadlinesFebruary 26, 2024 | msn.comInvesco BulletShares 2031 Corporate Bond ETF declares monthly distribution of $0.0612February 21, 2024 | investing.comInvesco BulletShares 2027 Corporate Bond ETF (BSCR)April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.February 6, 2024 | finance.yahoo.comInvesco BulletShares 2022 High Yield Corporate Bond ETF (BSJM)September 7, 2023 | investing.comInvesco Bulletshares 2032 Municipal Bond ETF (BSMW)August 17, 2023 | msn.comShort-Term Bond ETF (BSCN) Hits New 52-Week HighMay 22, 2023 | seekingalpha.comInvesco BulletShares 2030 Corporate Bond ETF declares monthly distribution of $0.0570February 20, 2023 | msn.comInvesco BulletShares 2029 Corporate Bond ETF declares monthly distribution of $0.0477April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.January 25, 2023 | msn.comInvesco BulletShares 2028 High Yield Corporate Bond ETF declares monthly distribution of $0.1167See More Headlines Receive BSCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco BulletShares 2022 Corporate Bond ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerInvesco Fund NameInvesco BulletShares 2022 Corporate Bond ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BSCM Inception Date7/17/2013 Fund ManagerPeter Hubbard, Jeffrey W. Kernagis, Gary T. Jones, Philip Fang, Richard Ose, Jeremy Neisewander WebN/A PhoneN/AFund Focus Asset ClassFixed Income BenchmarkBulletShares USD Corporate Bond 2022 Index CategoryCorporate FocusInvestment Grade Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$0.14 Average Daily Volume$540,885.10 Discount/Premium-0.02% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerSusquehanna Miscellaneous Outstanding Shares79,200,000BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> Invesco BulletShares 2022 Corporate Bond ETF ExpensesTypeBSCMInvestment Grade ETFsFixed Income ETFsNYSEARCA ETFsAll ETFsManagement Fee0.10%0.22%0.32%0.50%0.51%Other Expenses0.00%0.12%0.27%0.64%0.58%Total Expense0.10%0.25%0.40%0.74%0.70%Fee Waiver0.00%-0.15%-0.24%-0.68%-0.57%Net Expense0.10%0.22%0.35%0.58%0.58% Invesco BulletShares 2022 Corporate Bond ETF (BSCM)Full Holdings Details Similar ETFsFidelity Low Duration Bond ETFNASDAQ:FLDBStrive Enhanced Income Short Maturity ETFNYSE:BUXXiShares Inflation Hedged U.S. Aggregate Bond ETFNYSEARCA:AGIHETFMG Sit Ultra Short ETFNYSEARCA:VALTBondBloxx BBB Rated 1-5 Year Corporate Bond ETFNYSEARCA:BBBS BSCM ETF - Frequently Asked Questions How have BSCM shares performed in 2024? Invesco BulletShares 2022 Corporate Bond ETF's stock was trading at $21.16 on January 1st, 2024. Since then, BSCM stock has increased by 0.0% and is now trading at $21.16. View the best growth stocks for 2024 here. What does BSCM invest in? Invesco BulletShares 2022 Corporate Bond ETF is a fixed income fund issued by Invesco. BSCM focuses on investment grade investments and follows the BulletShares USD Corporate Bond 2022 Index. The fund's investments total to approximately $0.14 assets under management. What is the management fee for Invesco BulletShares 2022 Corporate Bond ETF? Invesco BulletShares 2022 Corporate Bond ETF's management fee is 0.10% and has no other recorded expenses or fee waivers. The net expense ratio for BSCM is 0.10%. What other stocks do shareholders of Invesco BulletShares 2022 Corporate Bond ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco BulletShares 2022 Corporate Bond ETF investors own include Intel (INTC), Invesco BulletShares 2021 Corporate Bond ETF (BSCL), CVS Health (CVS), Chevron (CVX), Duke Energy (DUK), Genuine Parts (GPC), Main Street Capital (MAIN), Southern (SO), AT&T (T) and Verizon Communications (VZ). How do I buy shares of Invesco BulletShares 2022 Corporate Bond ETF? Shares of BSCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:BSCM) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco BulletShares 2022 Corporate Bond ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.